As the number of patients treated with novel antidiabetic drugs continues to rise, the likelihood of encountering individuals in the perioperative setting is also surging
All GLP-1 receptor agonists cause similar modest heart rate increases of approximately 24 beats per minute on average, including liraglutide, semaglutide, dulaglutide, and tirzepatide
Patients should be educated about what normal medication appearance looks like and instructed to contact their pharmacy or healthcare provider if they notice any changes
That's why it's crucial to focus on healthy habits while you're on the medication so that your progress continues even once youve stopped
Alberta Blue Cross's 2026 drug pipeline report says GLP-1 receptor agonists remain a major cost driver for private plans and that overall GLP-1 therapy plan spend is unlikely to decline in future years, even as a semaglutide generic is expected in mid-2026
So we're going to continue to treat your, you know, that you might be able to draw some of those back, but we can't change what's happened in the past